News
$2m boost to translate cancer research from lab to patient
University of Queensland researchers have received $2 million from the National Health and Medical Research Council to improve understanding of prostate and breast cancer and expedite the translation of research outcomes.
The Development Grants scheme funds early-stage health and medical projects with a clear path to commercialisation and strong potential for intellectual property.
NHMRC Development Grants recipients:
Professor Gregory Monteith – improve a leading therapy for the treatment of advanced and refractory prostate cancer.
Associate Professor David Muller – develop needle-free mRNA vaccines for the protection from and treatment of HER2+ breast cancer.
Topics
Related articles
UQ reaches milestone for workplace inclusivity
The University of Queensland has received a platinum rating at the Australian LGBTQ+ Inclusion Awards for efforts to create a more inclusive and equitable workplace.
8 June 2026
UQ community celebrated with 2026 King’s Birthday Honours
A dermatologist dedicated to improving skin cancer detection and a trailblazing doctor advancing healthcare delivery to Indigenous communities are among UQ staff and alumni recognised in this year’s King’s Birthday Honours.
8 June 2026